b
r
c
r
c
l
e
n
f
communityacquir
pneumonia
cap
remain
frequent
caus
morbid
mortal
worldwid
even
industrialis
countri
incid
highest
among
children
age
year
last
two
year
three
intern
guidelin
updat
new
evid
concern
incid
aetiolog
manag
childhood
cap
still
major
problem
standardis
main
aim
review
consid
avail
data
concern
aetiolog
diagnosi
evalu
sever
treatment
paediatr
cap
analysi
literatur
show
number
unansw
question
concern
manag
cap
includ
definit
absenc
paediatr
cap
sever
score
difficulti
identifi
aetiolog
emerg
resist
frequent
respiratori
pathogen
wide
use
antiinfecti
agent
lack
inform
concern
chang
cap
epidemiolog
follow
introduct
vaccin
respiratori
pathogen
research
clearli
requir
variou
area
effort
need
increas
vaccin
coverag
alreadi
avail
vaccin
order
reduc
occurr
diseas
communityacquir
pneumonia
cap
remain
frequent
caus
morbid
mortal
worldwid
even
industrialis
countri
incid
highest
among
children
age
b
year
estim
cap
respons
onefifth
death
young
children
two
million
death
per
year
develop
develop
world
incid
cap
among
children
age
year
develop
countri
per
childyear
mortal
rate
north
america
europ
incid
preschool
children
still
approxim
per
childyear
extens
infant
vaccin
pneumococc
conjug
vaccin
develop
countri
significantli
decreas
rate
hospit
admiss
due
childhood
cap
concern
rais
increas
complic
cap
case
due
streptococcu
pneumonia
serotyp
last
year
furthermor
increas
death
due
staphylococc
pneumonia
report
north
america
mainli
follow
influenza
infect
last
two
year
three
intern
guidelin
updat
new
evid
concern
incid
aetiolog
manag
childhood
cap
howev
still
major
problem
standardis
manag
paediatr
cap
includ
lack
true
diagnost
standard
difficulti
identifi
caus
microorgan
select
antibiot
definit
cap
vari
wide
worldwid
depend
whether
chest
radiographi
use
furthermor
although
chest
radiographi
still
main
mean
confirm
clinic
suspicion
cap
everyday
practic
diagnost
accuraci
limit
signific
intraand
interobserv
differ
interpret
plain
chest
radiograph
furthermor
recent
intern
guidelin
manag
paediatr
cap
recommend
routin
radiolog
investig
patient
suspect
uncompl
cap
cap
requir
hospitalis
difficult
establish
real
incid
childhood
cap
term
therapi
firstlin
antimicrobi
approach
vari
countri
countri
clear
consensu
concern
secondlin
treatment
main
aim
review
consid
avail
data
concern
aetiolog
diagnosi
evalu
sever
treatment
paediatr
cap
use
molecular
method
detect
microbi
product
biolog
fluid
greatli
improv
knowledg
cap
aetiolog
new
respiratori
pathogen
discov
last
ten
year
includ
human
metapneumoviru
bocaviru
coronavirus
new
data
concern
import
differ
pneumococc
serotyp
impact
use
pneumococc
conjug
vaccin
collect
use
polymeras
chain
reaction
howev
determin
aetiolog
cap
still
difficult
routin
clinic
set
appropri
lower
respiratori
tract
specimen
rare
obtain
children
evalu
upper
respiratori
tract
secret
use
virus
atyp
bacteria
typic
bacteria
part
normal
flora
colonis
upper
respiratori
tract
detect
bacteri
antigen
urin
relat
flora
consid
aetiolog
marker
infect
children
aetiolog
cap
vari
significantli
depend
age
patient
respiratori
virus
frequent
pathogen
children
age
four
month
five
year
syncyti
viru
rhinoviru
main
virus
respons
approxim
cap
episod
hospitalis
children
pneumonia
account
onethird
case
age
mycoplasma
pneumonia
main
pathogen
children
age
year
also
account
case
children
age
year
untyp
haemophilu
influenza
staphylococcu
aureu
chlamydiophyla
pneumonia
much
less
frequent
observ
partli
lack
reliabl
diagnost
test
howev
mani
studi
publish
last
ten
year
record
mix
viralbacteri
infect
case
childhood
pneumonia
frequent
involv
bacteria
dual
viral
infect
also
report
two
three
virus
detect
case
virus
eg
bocaviru
detect
frequent
other
multipl
infect
clear
mean
clinic
practic
whether
viral
infect
alway
preced
bacteri
infect
although
clinic
radiolog
pictur
laboratori
find
characterist
particular
etiolog
agent
eg
paroxysm
cough
viral
atyp
bacteri
infect
necrotis
pneumonia
infect
due
aureu
pneumonia
latter
also
induc
signific
increas
none
suffici
sensit
specif
identifi
definit
mani
factor
associ
complic
cap
cours
includ
microbi
load
type
virul
pathogen
suscept
antiinfect
drug
host
suscept
infect
individu
suscept
cap
also
relat
presenc
comorbid
preexist
lung
diseas
bronchodysplasia
bronchiectasi
adenomatoid
cystic
malform
previou
vaccin
respiratori
pathogen
genet
suscept
infect
last
may
play
underestim
role
incid
clinic
cours
cap
patient
age
risk
cap
five
time
higher
adult
patient
discharg
hospitalis
cap
discharg
diagnosi
primari
care
set
seem
subject
cap
also
like
experienc
previous
recurr
upper
respiratori
infect
moreov
studi
adopt
patient
shown
risk
fatal
outcom
greatli
condit
genet
factor
seem
confirm
major
role
determin
individu
suscept
singl
nucleotid
polymorph
snp
mani
gene
involv
innat
adapt
immun
respons
associ
host
suscept
gene
also
associ
protect
suscept
infecti
diseas
cap
intern
guidelin
suggest
variou
criteria
assess
sever
cap
infant
older
children
gener
sign
symptom
suggest
respiratori
distress
ageadjust
tachypnea
level
less
room
air
cyanosi
chest
retract
nasal
flare
grunt
suggest
need
hospitalis
unlik
case
adult
valid
score
system
sensit
specif
enough
predict
children
suffici
sever
cap
warrant
cours
guidelin
also
point
child
overal
clinic
appear
behaviour
may
predict
sever
child
toxic
appear
includ
temperatur
n
tachycardia
capillari
refil
time
n
dehydr
respiratori
distress
admit
hospit
criteria
hospitalis
includ
younger
age
ie
month
preexist
comorbid
suspect
infect
due
methicillinresist
aureu
feed
difficulti
inabl
take
oral
medic
vomit
possibl
noncompli
oral
treatment
famili
environ
interest
perspect
open
discoveri
new
blood
biomark
cap
sever
adult
includ
natriuret
peptid
midregion
proadrenomedullin
trigger
receptor
express
myeloid
cell
howev
still
data
concern
role
biomark
paediatr
cap
although
radiograph
detect
infiltr
current
gold
standard
diagnosi
cap
expert
agre
routin
imag
studi
essenti
confirm
diagnosi
children
least
well
enough
treat
outpati
present
recurr
episod
howev
essenti
manag
sever
andor
recurr
cap
addit
confirm
diagnosi
also
document
characterist
parenchym
infiltr
presenc
complic
requir
specif
therapi
comput
tomographi
ct
usual
reserv
patient
cap
complic
parapneumon
effus
necrotis
pneumonia
lung
abscess
especi
surgeri
need
consid
chest
radiograph
less
sensit
detect
lung
abscess
ct
scan
fail
approxim
case
sever
parapneumon
effus
empyema
ie
half
chest
xray
opacifi
often
requir
ct
scan
placement
chest
tube
especi
locul
effus
suspect
case
lung
ultrasonographi
lu
may
altern
advantag
avoid
radiat
exposur
even
though
less
accur
give
rise
interobserv
disagr
ct
recent
prospect
multicentr
studi
aim
compar
accuraci
lu
plain
chest
radiographi
lowdos
ct
diagnos
adult
cap
found
sensit
confid
interv
ci
specif
ci
aetiolog
number
studi
shown
sign
symptom
viral
bacteri
cap
may
surprisingli
similar
radiolog
characterist
use
distinguish
differ
aetiolog
agent
nonmicrobiolog
laboratori
test
total
differenti
white
blood
cell
count
serum
creactiv
protein
level
erythrocyt
sediment
rate
often
use
decis
make
individu
case
procalcitonin
level
current
seem
best
marker
distinguish
bacteri
viral
cap
reduc
durat
antimicrobi
therapi
identifi
aetiolog
paediatr
cap
also
problem
microbiolog
method
use
detect
bacteria
risk
complic
mean
punctur
lung
punctur
bronchoalveolar
lavag
thoracoscop
lung
biopsi
reserv
complic
lifethreaten
case
respond
theoret
adequ
antibiot
therapi
blood
cultur
posit
children
complic
cap
fewer
mild
moder
diseas
molecular
method
increas
sensit
identifi
bacteri
pathogen
blood
sampl
routin
use
laboratori
gram
stain
cultur
expector
sputum
wide
use
identifi
bacteria
respons
adult
cap
children
particularli
first
year
life
provid
adequ
specimen
test
furthermor
otherwis
healthi
younger
children
frequent
carri
nasopharyng
bacteria
caus
cap
sputum
induc
contamin
often
lead
unreli
result
relat
atyp
bacteria
cultur
respiratori
secret
order
identifi
pneumonia
impract
laboratori
requir
specif
media
slow
growth
mean
take
long
obtain
inform
use
therapeut
decis
make
presenc
coldreact
antibodi
red
blood
cell
serum
consid
reliabl
index
pneumonia
infect
accuraci
never
evalu
children
current
recommend
paediatr
serolog
method
mainli
enzym
assay
detect
specif
igm
igg
antibodi
sensit
specif
good
two
serum
sampl
evalu
one
taken
acut
phase
one
convalesc
howev
although
use
epidemiolog
studi
find
use
make
therapeut
decis
final
pcrbase
test
theoret
sensit
specif
readili
avail
practic
consid
standard
mean
identifi
pneumonia
cap
diagnost
test
use
identifi
chlamydophila
pneumonia
even
limit
unreli
perform
mani
serolog
assay
poor
inadequ
valid
use
thought
identifi
capcaus
virus
upper
respiratori
secret
reliabl
believ
could
carri
healthi
children
howev
assumpt
wide
question
shown
true
virus
furthermor
viralbacteri
coinfect
frequent
bacteri
pathogen
may
play
import
role
condit
clinic
sign
symptom
patient
outcom
conclus
identifi
aetiolog
paediatr
cap
frequent
possibl
particularli
mild
moder
case
may
lead
unnecessari
prescript
antibiot
absenc
reliabl
marker
capabl
distinguish
viral
bacteri
cap
cap
caus
common
atyp
bacteria
treatment
remain
larg
empir
howev
distinct
seem
somewhat
artifici
childhood
cap
case
mix
aetiolog
guidelin
suggest
antimicrobi
therapi
routin
start
preschoolag
children
cap
viral
pathogen
may
respons
case
although
anoth
guidelin
state
children
clear
clinic
diagnosi
cap
receiv
antibiot
bacteri
viral
pneumonia
reliabl
distinguish
differ
antibiot
use
mildmoder
sever
complic
cap
factor
bear
mind
patient
age
presum
aetiolog
diseas
preval
antimicrobi
resist
pneumococc
vaccin
statu
first
four
week
life
tradit
use
combin
ampicillin
amoxicillin
aminoglycosid
mainli
gentamicin
remain
treatment
choic
broad
spectrum
parenter
cephalosporin
potenti
altern
patient
age
month
pneumonia
main
bacteri
caus
cap
antibiot
propos
firstlin
treatment
chlamydia
trachomati
bordetella
pertussi
consid
especi
presenc
littl
fever
sever
cough
macrolid
propos
children
age
four
month
five
year
main
bacteri
caus
agent
cap
still
pneumonia
atyp
bacteria
particularli
pneumonia
may
play
signific
role
especi
children
age
year
propos
drug
penicillin
g
aminopenicillin
wide
use
amoxicillin
clinic
failur
children
fulli
immunis
pneumonia
andor
h
influenza
type
b
could
treat
amoxicillinclavulan
thirdgener
cephalosporin
secondgener
cephalosporin
propos
area
low
preval
pneumonia
penicillin
resist
case
sever
cap
suspect
atyp
bacteria
consider
given
combin
therapi
drug
plu
macrolid
main
caus
cap
children
adolesc
age
year
pneumonia
although
pneumonia
still
play
signific
aetiolog
role
particularli
sever
case
macrolid
firstlin
drug
mild
moder
case
wherea
combin
macrolid
therapi
consid
sever
case
age
group
antistaphylococc
antibiot
consid
critic
ill
patient
approv
regular
treatment
children
lead
select
resist
strain
quinolon
use
select
case
effect
altern
eg
macrolideresist
pneumonia
infect
persist
symptom
children
immunoglobulin
emedi
allergi
recommend
durat
antimicrobi
therapi
day
mildmoder
cap
longer
eg
day
case
sever
andor
complic
cap
although
cap
one
frequent
paediatr
infecti
diseas
find
review
indic
number
unansw
question
concern
manag
includ
definit
cap
lack
paediatr
cap
sever
score
difficulti
identifi
aetiolog
diseas
resist
frequent
respiratori
pathogen
wide
use
antiinfecti
agent
lack
inform
concern
chang
cap
epidemiolog
follow
introduct
vaccin
respiratori
pathogen
research
clearli
requir
variou
area
effort
need
increas
vaccin
coverag
